Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5195209
Max Phase: Preclinical
Molecular Formula: C26H30O5
Molecular Weight: 422.52
Associated Items:
ID: ALA5195209
Max Phase: Preclinical
Molecular Formula: C26H30O5
Molecular Weight: 422.52
Associated Items:
Canonical SMILES: C=C(c1ccc(OCCO)c2ccccc12)C1COC2(OO1)C1CC3CC(C1)CC2C3
Standard InChI: InChI=1S/C26H30O5/c1-16(21-6-7-24(28-9-8-27)23-5-3-2-4-22(21)23)25-15-29-26(31-30-25)19-11-17-10-18(13-19)14-20(26)12-17/h2-7,17-20,25,27H,1,8-15H2
Standard InChI Key: IHKUHLIPTAEBEF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 422.52 | Molecular Weight (Monoisotopic): 422.2093 | AlogP: 4.72 | #Rotatable Bonds: 5 |
Polar Surface Area: 57.15 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.99 | CX LogD: 4.99 |
Aromatic Rings: 2 | Heavy Atoms: 31 | QED Weighted: 0.71 | Np Likeness Score: 0.82 |
1. Karnatak M, Hassam M, Vanangamudi M, Sharma S, Kumar Yadav D, Singh C, Puri SK, Rawat V, Prakash Verma V.. (2021) Novel naphthyl based 1,2,4-trioxanes: Synthesis and in vivo efficacy in the Plasmodium yoelii nigeriensis in Swiss mice., 51 [PMID:34547418] [10.1016/j.bmcl.2021.128372] |
Source(1):